Similar articles

• [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2012 Feb 23;154(3):82-3. MMW Fortschr Med. 2012. PMID: 22458177 German. No abstract available.
• [Revised blood pressure goals and no elevated glucose readings in between].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Dec 15;147(51-52):72. MMW Fortschr Med. 2005. PMID: 16402718 German. No abstract available.
• [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].

  Laakso M. Laakso M. Duodecim. 2003;119(20):1921-3. Duodecim. 2003. PMID: 14639996 Finnish. No abstract available.
• [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].

  Sjöholm A. Sjöholm A. Lakartidningen. 2001 Feb 28;98(9):937-40. Lakartidningen. 2001. PMID: 11292972 Review. Swedish.
• Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.

  Delorme S, Chiasson JL. Delorme S, et al. Curr Opin Pharmacol. 2005 Apr;5(2):184-9. doi: 10.1016/j.coph.2004.11.005. Curr Opin Pharmacol. 2005. PMID: 15780829 Review.